AFT Pharmaceuticals Limited (ASX:AFP)
Australia · Delayed Price · Currency is AUD 2.400
-0.090 (-3.61%)
Jul 31, 2025, 2:07 PM AEST
AFT Pharmaceuticals Company Description
AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally.
The company offers products for use in the areas of allergy, gastrointestinal, cold and flu, digestive health, eye care, first aid, nail care, pain management, skin care, vitamins, and supplements, as well as other products.
The company has collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy.
AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
AFT Pharmaceuticals Limited
| Country | New Zealand |
| Founded | 1997 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 119 |
| CEO | Hartley Atkinson |
Contact Details
Address: 129 Hurstmere Road Auckland, 0622 New Zealand | |
| Phone | 64 8 0042 3823 |
| Website | aftpharm.com |
Stock Details
| Ticker Symbol | AFP |
| Exchange | Australian Securities Exchange |
| Fiscal Year | April - March |
| Reporting Currency | NZD |
| ISIN Number | NZAFTE0001S4 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Hartley Atkinson Ph.D. | Co-Founder, Chief Executive Officer, MD and Executive Director |
| Marree Atkinson | Co-Founder, Chief of Staff and Executive Director |
| Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ | Chief Financial Officer and Company Secretary |
| Ioana Stanescu | Chief Scientific Officer |
| Murray Keith | Group Marketing Manager |